RareCyte is a life science research and diagnostic development company structured around characterizing and isolating rare cells from blood. The firm is developing innovative products for applications in life science, pathology and clinical research as well as drug development and diagnostics. Designed to help answer difficult questions related to cancer, prenatal health and infectious disease, RarCyte tools and solutions and technologies enable convenient preparation and sophisticated multiparametric phenotypic analysis of rare cells including individual rare cell capture and retrieval for genomic analysis. The firm's AccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells (CTCs) and circulating endothelial cells (CECs) from whole blood.
